Seres Therapeutics, Inc. (MCRB) Shareholders’ equity 2016–2025
Seres Therapeutics, Inc. (MCRB) shareholders’ equity at each fiscal year-end, per SEC filings.
$44.2MFY2025 · since FY2016: $132.6M → $44.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $44.2M | +220.8% |
| FY2024 | $13.8M | +130.7% |
| FY2023 | -$44.9M | -516.0% |
| FY2022 | $10.8M | -91.8% |
| FY2021 | $131.5M | -24.7% |
| FY2020 | $174.8M | +461.6% |
| FY2019 | -$48.3M | -0.6% |
| FY2018 | -$48.0M | -179.2% |
| FY2017 | $60.7M | -54.2% |
| FY2016 | $132.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice